PHY906(KD018), an Adjuvant Based on a 1800-Year-Old Chinese Medicine, Enhanced the Anti-Tumor Activity of Sorafenib by Changing the Tumor Microenvironment

Scientific Reports - United Kingdom
doi 10.1038/srep09384
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Antitumor Efficacy of Β-Elemene by Changing Tumor Inflammatory Environment and Tumor Microenvironment

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2020English

Anti-Tumor Effect of Liqi, a Traditional Chinese Medicine Prescription, in Tumor Bearing Mice

BMC Complementary and Alternative Medicine
MedicineAlternative MedicineComplementary
2009English

Something Old, Something New: The Tumor Microenvironment Comes of Age

Cancer Discovery
Oncology
2019English

Anti-Tumor Activity of an Anti-Endoglin Monoclonal Antibody Is Enhanced in Immunocompetent Mice

International Journal of Cancer
Cancer ResearchOncology
2008English

The Tumor Immunosuppressive Microenvironment Impairs the Therapy of Anti-Her2/Neu Antibody

Protein & Cell
BiochemistryBiotechnologyDrug DiscoveryCell BiologyMedicine
2012English

Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer

Breast Cancer: Basic and Clinical Research
Cancer ResearchOncology
2017English

Targeting the Tumor Microenvironment: Focus on Angiogenesis

Journal of Oncology
Oncology
2012English

Replicase-Based Plasmid DNA Shows Anti-Tumor Activity

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

Digitally Deconvolving the Tumor Microenvironment

Genome Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy